Log in

NASDAQ:CLXTCalyxt Stock Price, Forecast & News

$4.34
-0.12 (-2.69 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.30
Now: $4.34
$4.48
50-Day Range
$3.57
MA: $4.18
$4.83
52-Week Range
$2.40
Now: $4.34
$14.43
Volume33,567 shs
Average Volume69,914 shs
Market Capitalization$143.39 million
P/E RatioN/A
Dividend YieldN/A
Beta2.45
Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A.
Read More
Calyxt logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.1Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.92 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorConsumer Staples
Current SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.30 million
Book Value$1.59 per share

Profitability

Net Income$-39,610,000.00
Net Margins-455.07%

Miscellaneous

Employees50
Market Cap$143.39 million
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

How has Calyxt's stock been impacted by COVID-19 (Coronavirus)?

Calyxt's stock was trading at $3.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CLXT shares have increased by 29.9% and is now trading at $4.34. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Calyxt?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Calyxt.

When is Calyxt's next earnings date?

Calyxt is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Calyxt.

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) announced its earnings results on Thursday, May, 7th. The company reported ($0.34) EPS for the quarter, missing the Zacks' consensus estimate of ($0.33) by $0.01. The business had revenue of $2.38 million for the quarter. Calyxt had a negative net margin of 455.07% and a negative return on equity of 64.78%. View Calyxt's earnings history.

What guidance has Calyxt issued on next quarter's earnings?

Calyxt issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, March, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.862-15.322 million, compared to the consensus revenue estimate of $20.48 million.

What price target have analysts set for CLXT?

5 Wall Street analysts have issued 12-month price targets for Calyxt's shares. Their forecasts range from $4.00 to $10.00. On average, they anticipate Calyxt's share price to reach $7.00 in the next year. This suggests a possible upside of 61.3% from the stock's current price. View analysts' price targets for Calyxt.

Has Calyxt been receiving favorable news coverage?

Press coverage about CLXT stock has trended very negative recently, InfoTrie reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Calyxt earned a media sentiment score of -3.7 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutCalyxt.

Are investors shorting Calyxt?

Calyxt saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 309,300 shares, a drop of 10.7% from the April 30th total of 346,200 shares. Based on an average daily trading volume, of 102,700 shares, the days-to-cover ratio is presently 3.0 days. Approximately 3.0% of the shares of the stock are short sold. View Calyxt's Current Options Chain.

Who are some of Calyxt's key competitors?

What other stocks do shareholders of Calyxt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Ring Energy (REI), Ring Energy (REI), Cypress Semiconductor (CY), Molecular Templates (MTEM), AbbVie (ABBV), Advanced Micro Devices (AMD), Eaton (ETN), GW Pharmaceuticals PLC- (GWPH) and Intel (INTC).

Who are Calyxt's key executives?

Calyxt's management team includes the following people:
  • Mr. James A. Blome, Chief Exec. Officer (Age 56)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)
  • Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)
  • Mr. William F. Koschak, Chief Financial Officer (Age 50)
  • Mr. Eric Dutang, Principal Accounting Officer (Age 45)

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (1.99%), Columbus Hill Capital Management L.P. (1.52%), Nikko Asset Management Americas Inc. (1.51%), Sumitomo Mitsui Trust Holdings Inc. (1.51%), Nikko Asset Management Americas Inc. (1.51%) and State Street Corp (0.49%). Company insiders that own Calyxt stock include Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, James Blome, Manoj Sahoo, Michel Arbadji, Philippe Dumont, SA Cellectis, Travis Frey and Yves J Ribeill. View institutional ownership trends for Calyxt.

Which major investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Nikko Asset Management Americas Inc., Essex Investment Management Co. LLC, Parametric Portfolio Associates LLC, BlackRock Inc., and UBS Group AG. Company insiders that have sold Calyxt company stock in the last year include Manoj Sahoo, Philippe Dumont, and Yves J Ribeill. View insider buying and selling activity for Calyxt.

Which major investors are buying Calyxt stock?

CLXT stock was bought by a variety of institutional investors in the last quarter, including Columbus Hill Capital Management L.P., HighTower Advisors LLC, Two Sigma Investments LP, Oppenheimer & Co. Inc., Nuveen Asset Management LLC, State Street Corp, Wells Fargo & Company MN, and Geode Capital Management LLC. Company insiders that have bought Calyxt stock in the last two years include SA Cellectis, and Travis Frey. View insider buying and selling activity for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $4.34.

How big of a company is Calyxt?

Calyxt has a market capitalization of $143.39 million and generates $7.30 million in revenue each year. The company earns $-39,610,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. Calyxt employs 50 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is www.calyxt.com.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.